companiesSEC EDGAR
MoonLake Immunotherapeutics

SEC EDGAR published this disclosure on 2026-07-15. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001213900-26-078031
cik1821586
company nameMoonLake Immunotherapeutics
form8-K